comparemela.com

Expect to deliver 2023 total revenue of more than $210 million, at least 53% growth over 2022


Delivered 70,429 total test reports in 2023, an increase of 59% compared to 2022


Year-end 2023 cash,...

Related Keywords

Derek Maetzold ,Castle Biosciences ,Nasdaq ,Facebook ,Castle Biosciences Inc ,Instagram ,Linkedin ,Unaudited Fourth Quarter Ended ,Path Melanoma ,Unaudited Year Ended ,Cypher Barrett ,Cash Equivalents ,Marketable Investment ,Mypath Melanoma ,Markets ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.